nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—Risedronate—osteoporosis	0.434	1	CbGbCtD
Aminosalicylic Acid—Urinary tract disorder—Ibandronate—osteoporosis	0.00143	0.00455	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Ibandronate—osteoporosis	0.00142	0.00451	CcSEcCtD
Aminosalicylic Acid—Anaemia—Etidronic acid—osteoporosis	0.00141	0.00447	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Calcium Acetate—osteoporosis	0.00139	0.00443	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Ethinyl Estradiol—osteoporosis	0.00139	0.0044	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Etidronic acid—osteoporosis	0.00136	0.00433	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Ethinyl Estradiol—osteoporosis	0.00134	0.00425	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Estropipate—osteoporosis	0.00132	0.00418	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Zoledronate—osteoporosis	0.00131	0.00415	CcSEcCtD
Aminosalicylic Acid—Flatulence—Estropipate—osteoporosis	0.0013	0.00412	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Calcium Acetate—osteoporosis	0.00129	0.00411	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Estradiol—osteoporosis	0.00129	0.0041	CcSEcCtD
Aminosalicylic Acid—Flatulence—Alendronate—osteoporosis	0.00128	0.00406	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Alendronate—osteoporosis	0.00127	0.00403	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Ibandronate—osteoporosis	0.00126	0.00401	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Conjugated Estrogens—osteoporosis	0.00126	0.00399	CcSEcCtD
Aminosalicylic Acid—Flatulence—Raloxifene—osteoporosis	0.00126	0.00399	CcSEcCtD
Aminosalicylic Acid—Dizziness—Calcium Acetate—osteoporosis	0.00125	0.00397	CcSEcCtD
Aminosalicylic Acid—Flatulence—Ibandronate—osteoporosis	0.00124	0.00395	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Ibandronate—osteoporosis	0.00124	0.00393	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Ethinyl Estradiol—osteoporosis	0.00121	0.00384	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Calcitriol—osteoporosis	0.00121	0.00384	CcSEcCtD
Aminosalicylic Acid—Vomiting—Calcium Acetate—osteoporosis	0.0012	0.00382	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Ethinyl Estradiol—osteoporosis	0.0012	0.00382	CcSEcCtD
Aminosalicylic Acid—Purpura—Estradiol—osteoporosis	0.0012	0.00381	CcSEcCtD
Aminosalicylic Acid—Anaemia—Alendronate—osteoporosis	0.0012	0.00381	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Pamidronate—osteoporosis	0.00118	0.00375	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Risedronate—osteoporosis	0.00118	0.00375	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Zoledronate—osteoporosis	0.00117	0.00373	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Risedronate—osteoporosis	0.00117	0.00372	CcSEcCtD
Aminosalicylic Acid—Anaemia—Ibandronate—osteoporosis	0.00117	0.00371	CcSEcCtD
Aminosalicylic Acid—Nausea—Calcium Acetate—osteoporosis	0.00112	0.00357	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Pamidronate—osteoporosis	0.00112	0.00356	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Pamidronate—osteoporosis	0.00111	0.00354	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.00111	0.00353	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Conjugated Estrogens—osteoporosis	0.00109	0.00347	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Zoledronate—osteoporosis	0.00108	0.00343	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00108	0.00342	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00107	0.00339	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Ethinyl Estradiol—osteoporosis	0.00107	0.00339	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Estropipate—osteoporosis	0.00105	0.00335	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Estropipate—osteoporosis	0.00104	0.00331	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Risedronate—osteoporosis	0.00104	0.0033	CcSEcCtD
Aminosalicylic Acid—Flatulence—Risedronate—osteoporosis	0.00103	0.00326	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Zoledronate—osteoporosis	0.00102	0.00325	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Raloxifene—osteoporosis	0.00102	0.00324	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Raloxifene—osteoporosis	0.00102	0.00324	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Zoledronate—osteoporosis	0.00102	0.00323	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00102	0.00323	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Raloxifene—osteoporosis	0.00101	0.00321	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Ibandronate—osteoporosis	0.00101	0.00321	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Estradiol—osteoporosis	0.00101	0.00319	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Ibandronate—osteoporosis	0.001	0.00318	CcSEcCtD
Aminosalicylic Acid—Nausea—Ergocalciferol—osteoporosis	0.000992	0.00315	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Pamidronate—osteoporosis	0.000989	0.00314	CcSEcCtD
Aminosalicylic Acid—Urticaria—Etidronic acid—osteoporosis	0.000986	0.00313	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Etidronic acid—osteoporosis	0.000982	0.00312	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Calcitriol—osteoporosis	0.00098	0.00311	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Pamidronate—osteoporosis	0.000968	0.00308	CcSEcCtD
Aminosalicylic Acid—Anaemia—Risedronate—osteoporosis	0.000961	0.00305	CcSEcCtD
Aminosalicylic Acid—Anorexia—Calcitriol—osteoporosis	0.000961	0.00305	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Estropipate—osteoporosis	0.000927	0.00295	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Etidronic acid—osteoporosis	0.000915	0.00291	CcSEcCtD
Aminosalicylic Acid—Anaemia—Pamidronate—osteoporosis	0.000914	0.0029	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Estradiol—osteoporosis	0.000904	0.00287	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Zoledronate—osteoporosis	0.000903	0.00287	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000902	0.00287	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000898	0.00285	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Ibandronate—osteoporosis	0.000896	0.00284	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000889	0.00282	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Pamidronate—osteoporosis	0.000885	0.00281	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Zoledronate—osteoporosis	0.000885	0.00281	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00088	0.00279	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Estropipate—osteoporosis	0.000878	0.00279	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Calcitriol—osteoporosis	0.000877	0.00278	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Estradiol—osteoporosis	0.000873	0.00277	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Conjugated Estrogens—osteoporosis	0.00087	0.00276	CcSEcCtD
Aminosalicylic Acid—Jaundice—Estradiol—osteoporosis	0.000868	0.00276	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Alendronate—osteoporosis	0.000865	0.00275	CcSEcCtD
Aminosalicylic Acid—Flatulence—Conjugated Estrogens—osteoporosis	0.000857	0.00272	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000854	0.00271	CcSEcCtD
Aminosalicylic Acid—Urticaria—Estropipate—osteoporosis	0.000853	0.00271	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000852	0.00271	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Raloxifene—osteoporosis	0.000851	0.0027	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Etidronic acid—osteoporosis	0.00085	0.0027	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Estropipate—osteoporosis	0.000849	0.0027	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Estropipate—osteoporosis	0.000849	0.0027	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000846	0.00269	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Ibandronate—osteoporosis	0.000842	0.00268	CcSEcCtD
Aminosalicylic Acid—Urticaria—Alendronate—osteoporosis	0.000841	0.00267	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Alendronate—osteoporosis	0.000836	0.00266	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Alendronate—osteoporosis	0.000836	0.00266	CcSEcCtD
Aminosalicylic Acid—Anaemia—Zoledronate—osteoporosis	0.000835	0.00265	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Risedronate—osteoporosis	0.000833	0.00264	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Risedronate—osteoporosis	0.000825	0.00262	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Calcitriol—osteoporosis	0.000825	0.00262	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Raloxifene—osteoporosis	0.000823	0.00261	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Raloxifene—osteoporosis	0.000823	0.00261	CcSEcCtD
Aminosalicylic Acid—Urticaria—Ibandronate—osteoporosis	0.000818	0.0026	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Ibandronate—osteoporosis	0.000814	0.00259	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Ibandronate—osteoporosis	0.000814	0.00259	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Zoledronate—osteoporosis	0.000809	0.00257	CcSEcCtD
Aminosalicylic Acid—Urticaria—Calcitriol—osteoporosis	0.000801	0.00254	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Estradiol—osteoporosis	0.0008	0.00254	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Calcitriol—osteoporosis	0.000797	0.00253	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Calcitriol—osteoporosis	0.000797	0.00253	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Estropipate—osteoporosis	0.000791	0.00251	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Pamidronate—osteoporosis	0.000791	0.00251	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Pamidronate—osteoporosis	0.00079	0.00251	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Estradiol—osteoporosis	0.00079	0.00251	CcSEcCtD
Aminosalicylic Acid—Vomiting—Etidronic acid—osteoporosis	0.00079	0.00251	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Estradiol—osteoporosis	0.000784	0.00249	CcSEcCtD
Aminosalicylic Acid—Rash—Etidronic acid—osteoporosis	0.000783	0.00249	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Etidronic acid—osteoporosis	0.000782	0.00248	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Alendronate—osteoporosis	0.00078	0.00248	CcSEcCtD
Aminosalicylic Acid—Headache—Etidronic acid—osteoporosis	0.000778	0.00247	CcSEcCtD
Aminosalicylic Acid—Anorexia—Pamidronate—osteoporosis	0.000769	0.00244	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000764	0.00243	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Ibandronate—osteoporosis	0.000759	0.00241	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000752	0.00239	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Calcitriol—osteoporosis	0.000743	0.00236	CcSEcCtD
Aminosalicylic Acid—Nausea—Etidronic acid—osteoporosis	0.000738	0.00234	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000735	0.00234	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Estropipate—osteoporosis	0.000735	0.00233	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Risedronate—osteoporosis	0.000733	0.00233	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Alendronate—osteoporosis	0.000724	0.0023	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Zoledronate—osteoporosis	0.000723	0.0023	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Zoledronate—osteoporosis	0.000722	0.00229	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Zoledronate—osteoporosis	0.000716	0.00227	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000712	0.00226	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Raloxifene—osteoporosis	0.000712	0.00226	CcSEcCtD
Aminosalicylic Acid—Dizziness—Estropipate—osteoporosis	0.00071	0.00226	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Ibandronate—osteoporosis	0.000705	0.00224	CcSEcCtD
Aminosalicylic Acid—Anorexia—Zoledronate—osteoporosis	0.000703	0.00223	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Pamidronate—osteoporosis	0.000702	0.00223	CcSEcCtD
Aminosalicylic Acid—Dizziness—Alendronate—osteoporosis	0.0007	0.00222	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000697	0.00221	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000696	0.00221	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Estradiol—osteoporosis	0.000696	0.00221	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Risedronate—osteoporosis	0.000694	0.00221	CcSEcCtD
Aminosalicylic Acid—Urticaria—Ethinyl Estradiol—osteoporosis	0.000692	0.0022	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Calcitriol—osteoporosis	0.00069	0.00219	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Conjugated Estrogens—osteoporosis	0.000689	0.00219	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000688	0.00219	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000688	0.00219	CcSEcCtD
Aminosalicylic Acid—Dizziness—Raloxifene—osteoporosis	0.000688	0.00219	CcSEcCtD
Aminosalicylic Acid—Flatulence—Estradiol—osteoporosis	0.000686	0.00218	CcSEcCtD
Aminosalicylic Acid—Vomiting—Estropipate—osteoporosis	0.000683	0.00217	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Estradiol—osteoporosis	0.000682	0.00217	CcSEcCtD
Aminosalicylic Acid—Dizziness—Ibandronate—osteoporosis	0.000681	0.00216	CcSEcCtD
Aminosalicylic Acid—Rash—Estropipate—osteoporosis	0.000677	0.00215	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Estropipate—osteoporosis	0.000677	0.00215	CcSEcCtD
Aminosalicylic Acid—Anorexia—Conjugated Estrogens—osteoporosis	0.000677	0.00215	CcSEcCtD
Aminosalicylic Acid—Urticaria—Risedronate—osteoporosis	0.000674	0.00214	CcSEcCtD
Aminosalicylic Acid—Headache—Estropipate—osteoporosis	0.000673	0.00214	CcSEcCtD
Aminosalicylic Acid—Vomiting—Alendronate—osteoporosis	0.000673	0.00214	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Risedronate—osteoporosis	0.000671	0.00213	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Risedronate—osteoporosis	0.000671	0.00213	CcSEcCtD
Aminosalicylic Acid—Rash—Alendronate—osteoporosis	0.000667	0.00212	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Alendronate—osteoporosis	0.000667	0.00212	CcSEcCtD
Aminosalicylic Acid—Headache—Alendronate—osteoporosis	0.000663	0.00211	CcSEcCtD
Aminosalicylic Acid—Vomiting—Raloxifene—osteoporosis	0.000662	0.0021	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Pamidronate—osteoporosis	0.00066	0.0021	CcSEcCtD
Aminosalicylic Acid—Rash—Raloxifene—osteoporosis	0.000656	0.00208	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Raloxifene—osteoporosis	0.000655	0.00208	CcSEcCtD
Aminosalicylic Acid—Vomiting—Ibandronate—osteoporosis	0.000655	0.00208	CcSEcCtD
Aminosalicylic Acid—Headache—Raloxifene—osteoporosis	0.000652	0.00207	CcSEcCtD
Aminosalicylic Acid—Rash—Ibandronate—osteoporosis	0.00065	0.00206	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Ibandronate—osteoporosis	0.000649	0.00206	CcSEcCtD
Aminosalicylic Acid—Headache—Ibandronate—osteoporosis	0.000645	0.00205	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000642	0.00204	CcSEcCtD
Aminosalicylic Acid—Vomiting—Calcitriol—osteoporosis	0.000641	0.00204	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Zoledronate—osteoporosis	0.000641	0.00204	CcSEcCtD
Aminosalicylic Acid—Nausea—Estropipate—osteoporosis	0.000638	0.00203	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Pamidronate—osteoporosis	0.000638	0.00203	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Pamidronate—osteoporosis	0.000638	0.00203	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000636	0.00202	CcSEcCtD
Aminosalicylic Acid—Rash—Calcitriol—osteoporosis	0.000636	0.00202	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Calcitriol—osteoporosis	0.000635	0.00202	CcSEcCtD
Aminosalicylic Acid—Headache—Calcitriol—osteoporosis	0.000632	0.00201	CcSEcCtD
Aminosalicylic Acid—Nausea—Alendronate—osteoporosis	0.000628	0.002	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Risedronate—osteoporosis	0.000625	0.00199	CcSEcCtD
Aminosalicylic Acid—Nausea—Raloxifene—osteoporosis	0.000618	0.00196	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000617	0.00196	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000613	0.00195	CcSEcCtD
Aminosalicylic Acid—Nausea—Ibandronate—osteoporosis	0.000612	0.00194	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Zoledronate—osteoporosis	0.000603	0.00191	CcSEcCtD
Aminosalicylic Acid—Nausea—Calcitriol—osteoporosis	0.000599	0.0019	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000596	0.00189	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Pamidronate—osteoporosis	0.000595	0.00189	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000589	0.00187	CcSEcCtD
Aminosalicylic Acid—Urticaria—Zoledronate—osteoporosis	0.000586	0.00186	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Zoledronate—osteoporosis	0.000583	0.00185	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Zoledronate—osteoporosis	0.000583	0.00185	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Risedronate—osteoporosis	0.000581	0.00185	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00058	0.00184	CcSEcCtD
Aminosalicylic Acid—Dizziness—Ethinyl Estradiol—osteoporosis	0.000576	0.00183	CcSEcCtD
Aminosalicylic Acid—Urticaria—Conjugated Estrogens—osteoporosis	0.000564	0.00179	CcSEcCtD
Aminosalicylic Acid—Dizziness—Risedronate—osteoporosis	0.000561	0.00178	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000561	0.00178	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000561	0.00178	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Estradiol—osteoporosis	0.000557	0.00177	CcSEcCtD
Aminosalicylic Acid—Vomiting—Ethinyl Estradiol—osteoporosis	0.000554	0.00176	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Pamidronate—osteoporosis	0.000552	0.00175	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Estradiol—osteoporosis	0.000552	0.00175	CcSEcCtD
Aminosalicylic Acid—Rash—Ethinyl Estradiol—osteoporosis	0.000549	0.00174	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000549	0.00174	CcSEcCtD
Aminosalicylic Acid—Headache—Ethinyl Estradiol—osteoporosis	0.000545	0.00173	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Zoledronate—osteoporosis	0.000543	0.00173	CcSEcCtD
Aminosalicylic Acid—Vomiting—Risedronate—osteoporosis	0.00054	0.00171	CcSEcCtD
Aminosalicylic Acid—Rash—Risedronate—osteoporosis	0.000535	0.0017	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Risedronate—osteoporosis	0.000535	0.0017	CcSEcCtD
Aminosalicylic Acid—Dizziness—Pamidronate—osteoporosis	0.000534	0.0017	CcSEcCtD
Aminosalicylic Acid—Headache—Risedronate—osteoporosis	0.000532	0.00169	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000523	0.00166	CcSEcCtD
Aminosalicylic Acid—Nausea—Ethinyl Estradiol—osteoporosis	0.000517	0.00164	CcSEcCtD
Aminosalicylic Acid—Vomiting—Pamidronate—osteoporosis	0.000513	0.00163	CcSEcCtD
Aminosalicylic Acid—Rash—Pamidronate—osteoporosis	0.000509	0.00162	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Pamidronate—osteoporosis	0.000508	0.00161	CcSEcCtD
Aminosalicylic Acid—Headache—Pamidronate—osteoporosis	0.000506	0.00161	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Zoledronate—osteoporosis	0.000504	0.0016	CcSEcCtD
Aminosalicylic Acid—Nausea—Risedronate—osteoporosis	0.000504	0.0016	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Estradiol—osteoporosis	0.000494	0.00157	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Estradiol—osteoporosis	0.00049	0.00156	CcSEcCtD
Aminosalicylic Acid—Dizziness—Zoledronate—osteoporosis	0.000487	0.00155	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000486	0.00154	CcSEcCtD
Aminosalicylic Acid—Nausea—Pamidronate—osteoporosis	0.000479	0.00152	CcSEcCtD
Aminosalicylic Acid—Dizziness—Conjugated Estrogens—osteoporosis	0.000469	0.00149	CcSEcCtD
Aminosalicylic Acid—Vomiting—Zoledronate—osteoporosis	0.000469	0.00149	CcSEcCtD
Aminosalicylic Acid—Rash—Zoledronate—osteoporosis	0.000465	0.00148	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Estradiol—osteoporosis	0.000465	0.00148	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Zoledronate—osteoporosis	0.000464	0.00148	CcSEcCtD
Aminosalicylic Acid—Headache—Zoledronate—osteoporosis	0.000462	0.00147	CcSEcCtD
Aminosalicylic Acid—Vomiting—Conjugated Estrogens—osteoporosis	0.000451	0.00143	CcSEcCtD
Aminosalicylic Acid—Urticaria—Estradiol—osteoporosis	0.000451	0.00143	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Estradiol—osteoporosis	0.000449	0.00143	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Estradiol—osteoporosis	0.000449	0.00143	CcSEcCtD
Aminosalicylic Acid—Rash—Conjugated Estrogens—osteoporosis	0.000448	0.00142	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Conjugated Estrogens—osteoporosis	0.000447	0.00142	CcSEcCtD
Aminosalicylic Acid—Headache—Conjugated Estrogens—osteoporosis	0.000445	0.00141	CcSEcCtD
Aminosalicylic Acid—Nausea—Zoledronate—osteoporosis	0.000438	0.00139	CcSEcCtD
Aminosalicylic Acid—Nausea—Conjugated Estrogens—osteoporosis	0.000422	0.00134	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Estradiol—osteoporosis	0.000419	0.00133	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Estradiol—osteoporosis	0.000389	0.00123	CcSEcCtD
Aminosalicylic Acid—Dizziness—Estradiol—osteoporosis	0.000376	0.00119	CcSEcCtD
Aminosalicylic Acid—Vomiting—Estradiol—osteoporosis	0.000361	0.00115	CcSEcCtD
Aminosalicylic Acid—Rash—Estradiol—osteoporosis	0.000358	0.00114	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Estradiol—osteoporosis	0.000358	0.00114	CcSEcCtD
Aminosalicylic Acid—Headache—Estradiol—osteoporosis	0.000356	0.00113	CcSEcCtD
Aminosalicylic Acid—Nausea—Estradiol—osteoporosis	0.000337	0.00107	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	0.000184	0.000731	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6R—osteoporosis	0.000181	0.00072	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—osteoporosis	0.000181	0.00072	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—TPI1—osteoporosis	0.000181	0.000719	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TNF—osteoporosis	0.000175	0.000698	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IRS2—osteoporosis	0.000173	0.000687	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—P4HB—osteoporosis	0.00017	0.000676	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IRS2—osteoporosis	0.00017	0.000675	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—LRP5—osteoporosis	0.000169	0.000674	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SOST—osteoporosis	0.000169	0.000673	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GAPDH—osteoporosis	0.000167	0.000664	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000166	0.000658	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 cascade initiated on plasma membrane—IL6—osteoporosis	0.000164	0.000651	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—RAP1A—osteoporosis	0.000163	0.000646	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoporosis	0.000162	0.000645	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—LRP6—osteoporosis	0.000162	0.000644	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	0.000161	0.000641	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—POMC—osteoporosis	0.000161	0.00064	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PSMA5—osteoporosis	0.00016	0.000638	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PSMA2—osteoporosis	0.00016	0.000638	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Biological oxidations—POMC—osteoporosis	0.00016	0.000636	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRAK3—osteoporosis	0.00016	0.000636	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 dependent cascade initiated on endosome—IL6—osteoporosis	0.000159	0.000634	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—IL6—osteoporosis	0.000157	0.000622	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—RPL24—osteoporosis	0.000156	0.000619	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—LTF—osteoporosis	0.000156	0.000619	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000155	0.000615	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—IL6—osteoporosis	0.000154	0.000611	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoporosis	0.000154	0.000611	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CALCR—osteoporosis	0.000153	0.000608	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTH1R—osteoporosis	0.000153	0.000608	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—osteoporosis	0.000151	0.000601	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PKM—osteoporosis	0.000151	0.0006	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—FDPS—osteoporosis	0.000151	0.0006	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IRS1—osteoporosis	0.000151	0.0006	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IRS1—osteoporosis	0.000148	0.00059	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	0.000147	0.000586	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ACTG1—osteoporosis	0.000146	0.000581	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—IL6—osteoporosis	0.000145	0.000577	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GPD2—osteoporosis	0.000143	0.000569	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PGLS—osteoporosis	0.000143	0.000569	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PKM—osteoporosis	0.000143	0.000569	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SOST—osteoporosis	0.000143	0.000569	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000142	0.000564	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6R—osteoporosis	0.000142	0.000563	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—IL6—osteoporosis	0.000142	0.000563	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—KL—osteoporosis	0.000141	0.000562	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6R—osteoporosis	0.000139	0.000554	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—MYC—osteoporosis	0.000138	0.000547	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TNF—osteoporosis	0.000137	0.000545	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—KL—osteoporosis	0.000136	0.00054	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ANTXR2—osteoporosis	0.000136	0.000539	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PGLS—osteoporosis	0.000136	0.000539	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL6—osteoporosis	0.000135	0.000538	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ACP5—osteoporosis	0.000135	0.000537	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000131	0.000523	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ENO1—osteoporosis	0.000131	0.000522	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ATIC—osteoporosis	0.000131	0.00052	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PNP—osteoporosis	0.000131	0.00052	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—IL6—osteoporosis	0.00013	0.000519	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	0.00013	0.000518	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.00013	0.000516	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PSMA5—osteoporosis	0.000129	0.000515	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PSMA2—osteoporosis	0.000129	0.000515	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	0.000127	0.000507	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TPI1—osteoporosis	0.000126	0.000499	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—osteoporosis	0.000123	0.000488	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RAP1A—osteoporosis	0.000122	0.000486	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MGLL—osteoporosis	0.000122	0.000483	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTSK—osteoporosis	0.000121	0.000482	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PKM—osteoporosis	0.00012	0.000477	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—FDPS—osteoporosis	0.00012	0.000477	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NFATC1—osteoporosis	0.000119	0.000474	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	0.000119	0.000473	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LRP5—osteoporosis	0.000119	0.000472	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—P4HB—osteoporosis	0.000118	0.000469	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	0.000117	0.000465	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—GAPDH—osteoporosis	0.000116	0.00046	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GSN—osteoporosis	0.000115	0.000459	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000114	0.000453	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000114	0.000452	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GPD2—osteoporosis	0.000114	0.000452	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PGLS—osteoporosis	0.000114	0.000452	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LRP6—osteoporosis	0.000113	0.000451	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000112	0.000447	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—OXCT1—osteoporosis	0.000111	0.000443	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CA2—osteoporosis	0.000111	0.000443	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—AGER—osteoporosis	0.000111	0.000442	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—ADCY5—osteoporosis	0.000111	0.00044	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	0.000111	0.000439	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NFATC1—osteoporosis	0.00011	0.000438	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—IL6—osteoporosis	0.000109	0.000435	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—IL6—osteoporosis	0.000109	0.000435	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—DKK1—osteoporosis	0.000109	0.000434	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MGLL—osteoporosis	0.000108	0.000431	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL1B—osteoporosis	0.000108	0.000429	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000106	0.000422	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—WNT1—osteoporosis	0.000105	0.000418	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CYP19A1—osteoporosis	0.000105	0.000418	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—IL6—osteoporosis	0.000105	0.000416	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ATIC—osteoporosis	0.000104	0.000413	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PNP—osteoporosis	0.000104	0.000413	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—IL6—osteoporosis	0.000103	0.000409	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGA—osteoporosis	0.000102	0.000407	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000102	0.000407	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—LRP5—osteoporosis	0.0001	0.000399	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MYC—osteoporosis	9.93e-05	0.000395	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	9.91e-05	0.000394	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—IL6—osteoporosis	9.83e-05	0.000391	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—IL6—osteoporosis	9.78e-05	0.000389	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—IL6—osteoporosis	9.73e-05	0.000387	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PSMA2—osteoporosis	9.73e-05	0.000387	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PSMA5—osteoporosis	9.73e-05	0.000387	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IRS2—osteoporosis	9.69e-05	0.000385	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—IL6—osteoporosis	9.69e-05	0.000385	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—LRP6—osteoporosis	9.6e-05	0.000382	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TLN1—osteoporosis	9.58e-05	0.000381	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	9.44e-05	0.000375	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—IRS2—osteoporosis	9.31e-05	0.00037	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—osteoporosis	9.25e-05	0.000368	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—IDH2—osteoporosis	9.22e-05	0.000367	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RPL24—osteoporosis	9.22e-05	0.000367	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—LTF—osteoporosis	9.22e-05	0.000367	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ENO1—osteoporosis	9.12e-05	0.000363	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	9.11e-05	0.000362	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—IL6—osteoporosis	9.11e-05	0.000362	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—IL6—osteoporosis	9.11e-05	0.000362	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—IL6—osteoporosis	9.03e-05	0.000359	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PSMA2—osteoporosis	8.99e-05	0.000357	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PSMA5—osteoporosis	8.99e-05	0.000357	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—IL6—osteoporosis	8.95e-05	0.000356	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—IL6—osteoporosis	8.91e-05	0.000354	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—OXCT1—osteoporosis	8.84e-05	0.000351	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CA2—osteoporosis	8.84e-05	0.000351	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP27A1—osteoporosis	8.67e-05	0.000345	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MGLL—osteoporosis	8.61e-05	0.000342	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ADCY5—osteoporosis	8.58e-05	0.000341	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GPX1—osteoporosis	8.55e-05	0.00034	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IRS1—osteoporosis	8.46e-05	0.000336	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ACP5—osteoporosis	8.44e-05	0.000335	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CALCA—osteoporosis	8.37e-05	0.000333	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.33e-05	0.000331	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—P4HB—osteoporosis	8.26e-05	0.000329	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—KL—osteoporosis	8.24e-05	0.000327	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—IRS1—osteoporosis	8.12e-05	0.000323	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.12e-05	0.000323	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	8.07e-05	0.000321	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTH—osteoporosis	8.04e-05	0.00032	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ACP5—osteoporosis	8e-05	0.000318	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6R—osteoporosis	7.95e-05	0.000316	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RAP1A—osteoporosis	7.9e-05	0.000314	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MTHFR—osteoporosis	7.9e-05	0.000314	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—TPI1—osteoporosis	7.84e-05	0.000312	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CNR2—osteoporosis	7.83e-05	0.000311	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NFATC1—osteoporosis	7.71e-05	0.000306	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—DKK1—osteoporosis	7.65e-05	0.000304	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—KL—osteoporosis	7.6e-05	0.000302	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL6—osteoporosis	7.47e-05	0.000297	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TPI1—osteoporosis	7.43e-05	0.000296	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—P4HB—osteoporosis	7.37e-05	0.000293	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—WNT1—osteoporosis	7.37e-05	0.000293	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—IDH2—osteoporosis	7.32e-05	0.000291	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GAPDH—osteoporosis	7.24e-05	0.000288	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGA—osteoporosis	7.16e-05	0.000285	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—RAP1A—osteoporosis	7.05e-05	0.00028	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—P4HB—osteoporosis	6.99e-05	0.000278	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP27A1—osteoporosis	6.88e-05	0.000274	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GAPDH—osteoporosis	6.86e-05	0.000273	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.76e-05	0.000269	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.74e-05	0.000268	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ACP5—osteoporosis	6.7e-05	0.000266	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTHLH—osteoporosis	6.66e-05	0.000265	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BMP2—osteoporosis	6.66e-05	0.000265	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.61e-05	0.000263	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NFATC1—osteoporosis	6.52e-05	0.000259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGB—osteoporosis	6.52e-05	0.000259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AGER—osteoporosis	6.47e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—DKK1—osteoporosis	6.47e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ADCY5—osteoporosis	6.45e-05	0.000256	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—POMC—osteoporosis	6.31e-05	0.000251	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6—osteoporosis	6.31e-05	0.000251	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	6.29e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PSMA5—osteoporosis	6.29e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PSMA2—osteoporosis	6.29e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—WNT1—osteoporosis	6.23e-05	0.000248	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—TPI1—osteoporosis	6.23e-05	0.000248	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—osteoporosis	6.21e-05	0.000247	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.15e-05	0.000244	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGA—osteoporosis	6.06e-05	0.000241	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ADCY5—osteoporosis	5.96e-05	0.000237	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CALCA—osteoporosis	5.86e-05	0.000233	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—P4HB—osteoporosis	5.85e-05	0.000233	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GAPDH—osteoporosis	5.75e-05	0.000228	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ENO1—osteoporosis	5.7e-05	0.000227	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRS2—osteoporosis	5.64e-05	0.000224	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PSMA2—osteoporosis	5.62e-05	0.000223	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PSMA5—osteoporosis	5.62e-05	0.000223	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—RAP1A—osteoporosis	5.6e-05	0.000222	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTHFR—osteoporosis	5.48e-05	0.000218	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ENO1—osteoporosis	5.4e-05	0.000215	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—KL—osteoporosis	5.32e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PSMA2—osteoporosis	5.32e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PSMA5—osteoporosis	5.32e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IRS2—osteoporosis	5.21e-05	0.000207	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CALCA—osteoporosis	4.96e-05	0.000197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRS1—osteoporosis	4.93e-05	0.000196	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.88e-05	0.000194	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6R—osteoporosis	4.63e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP19A1—osteoporosis	4.56e-05	0.000181	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IRS1—osteoporosis	4.55e-05	0.000181	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ENO1—osteoporosis	4.52e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—KL—osteoporosis	4.5e-05	0.000179	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PSMA2—osteoporosis	4.46e-05	0.000177	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PSMA5—osteoporosis	4.46e-05	0.000177	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6R—osteoporosis	4.27e-05	0.00017	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADCY5—osteoporosis	4.17e-05	0.000166	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SPP1—osteoporosis	4.04e-05	0.00016	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ADCY5—osteoporosis	3.72e-05	0.000148	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GPX1—osteoporosis	3.71e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IRS2—osteoporosis	3.65e-05	0.000145	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP19A1—osteoporosis	3.62e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LEP—osteoporosis	3.57e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—osteoporosis	3.54e-05	0.000141	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ADCY5—osteoporosis	3.53e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1B—osteoporosis	3.52e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—osteoporosis	3.42e-05	0.000136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ESR1—osteoporosis	3.41e-05	0.000136	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—osteoporosis	3.25e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IRS1—osteoporosis	3.19e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IRS2—osteoporosis	3.09e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—POMC—osteoporosis	3.07e-05	0.000122	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6R—osteoporosis	2.99e-05	0.000119	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ADCY5—osteoporosis	2.95e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IGF1—osteoporosis	2.95e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GPX1—osteoporosis	2.94e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—POMC—osteoporosis	2.74e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—osteoporosis	2.72e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IRS1—osteoporosis	2.7e-05	0.000107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MYC—osteoporosis	2.53e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6R—osteoporosis	2.53e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—osteoporosis	2.53e-05	0.0001	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—POMC—osteoporosis	2.17e-05	8.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—osteoporosis	2.06e-05	8.2e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—osteoporosis	1.9e-05	7.57e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MYC—osteoporosis	1.77e-05	7.05e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—osteoporosis	1.77e-05	7.03e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MYC—osteoporosis	1.5e-05	5.96e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—osteoporosis	1.5e-05	5.95e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—osteoporosis	1.33e-05	5.3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—osteoporosis	1.13e-05	4.48e-05	CbGpPWpGaD
